Products

Borealis HDPE HE2581-PH

    • Product Name: Borealis HDPE HE2581-PH
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 777587
    Density 958 kg/m³
    Melt Flow Rate 190 C 5 Kg 0.25 g/10 min
    Tensile Modulus 1100 MPa
    Tensile Stress At Yield 25 MPa
    Tensile Strain At Break >600 %
    Charpy Notched Impact Strength 23 C 15 kJ/m²
    Charpy Notched Impact Strength 30 C 10 kJ/m²
    Vicat Softening Temperature 80 °C
    Thermal Conductivity 0.40 W/(m·K)
    Melting Point 130 °C
    Water Absorption 0.01 %
    Hardness Shore D 62
    Dielectric Strength 25 kV/mm
    Volume Resistivity 1e16 Ω·cm
    Carbon Black Content 2.3 %
    Oxidation Induction Time 200 C >20 min

    As an accredited Borealis HDPE HE2581-PH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Borealis HDPE HE2581-PH is packaged in 25 kg polyethylene bags, typically palletized and stretch-wrapped for secure transport.
    Container Loading (20′ FCL) 20′ FCL: Borealis HDPE HE2581-PH in 25 kg bags; typically 20–25 MT, palletized or loose, subject to container weight limits.
    Shipping Borealis HDPE HE2581-PH is a non-hazardous high-density polyethylene resin supplied as solid pellets. It is typically shipped in 25 kg bags, octabins, or bulk containers/trucks under dry conditions. Not classified as dangerous goods; no UN number. Store cool and dry, away from direct sunlight. Follow the SDS.
    Storage Store Borealis HDPE HE2581-PH in a cool, dry, well-ventilated warehouse, away from direct sunlight, heat, ignition sources, and strong oxidizers. Keep in original, sealed packaging, palletized and off the ground. Avoid moisture, dust, and contamination. Stack securely to prevent deformation. Use first-in, first-out rotation and follow the manufacturer’s SDS and local regulations.
    Shelf Life Borealis HDPE HE2581-PH has a 2-year shelf life from production when stored unopened under dry, cool conditions, protected from sunlight.
    Application of Borealis HDPE HE2581-PH

    Under the compressive load of a child-resistant closure engaged onto a 28 mm finish, Borealis HDPE HE2581-PH must balance a nominal melt flow rate of 25 g/10 min under ISO 1133-1:2022 and density of 0.958 g/cm³ under ISO 1183-1:2019 against the dimensional stability required to prevent back-off torque loss after repeated opening cycles conducted under ISO 8317:2015. Material compliance for pharmaceutical closure systems is anchored to FDA 21 CFR 177.1520, USP <661.1>, European Pharmacopoeia monograph 3.1.3, and, where child-resistant mechanisms are present, ISO 8317:2015 and 16 CFR 1700.20. Formulation addition ratio on production lines is typically 98.0–99.5 wt% HE2581-PH, 0.5–2.0 wt% pharmaceutical white masterbatch, and 0.05–0.20 wt% acid scavenger/processing aid; regrind from the same closure family may be added up to 15 wt% only after correlation of torque retention and extractables according to USP <661.1>. Injection moulding is performed on hydraulic or all-electric machines with clamp force 80–250 t, a 20:1–22:1 L/D reciprocating screw, compression ratio 2.0:1–2.5:1, shot size held between 20% and 60% of barrel capacity, melt temperature 200–230 °C, mould temperature 10–30 °C, injection speed 80–150 mm/s, holding pressure 30–60 MPa, back pressure 0.5–1.5 MPa, and cooling time 6–15 s. Hot-runner manifolds are maintained at 210–240 °C; residence time above 230 °C must not exceed 5 min, and start-up purge is monitored for MFR drift exceeding 2 g/10 min against the nominal 25 g/10 min value because oxidative degradation changes cap torque and thread dimensional stability. Terminal product types include 28 mm and 38 mm child-resistant closures, tamper-evident dispensing closures for liquid syrups, and graduated dosage cups.

    What Limits Ethylene Oxide Sterilisation Compatibility in Moulded Device Components?

    Because ethylene oxide cycles expose injection-moulded HDPE to controlled humidity at 40–80% RH and temperatures of 50–60 °C, the moulding process must minimise residual mould-release agents that can react or retain ethylene oxide residues above the ISO 10993-7:2008 limit. Biocompatibility evaluation follows ISO 10993-1:2018 for surface-contacting non-implant components, with ISO 10993-5:2009 cytotoxicity testing and ISO 10993-7:2008 for residual ethylene oxide and ethylene chlorohydrin. The permissible blend window is constrained to 99.0–100 wt% HE2581-PH with 0–1.0 wt% medical-grade masterbatch; external mould-release sprays are replaced by polished tooling and positive draft angles because even 0.1 wt% migrating lubricant can shift the ethylene oxide residue profile. Injection moulding parameters are set at melt temperature 190–215 °C, mould temperature 15–40 °C, holding pressure 25–50 MPa, and back pressure 0.3–1.0 MPa; venting is balanced to prevent localised burn marks that can later act as adsorption sites for ethylene chlorohydrin. Post-moulding ethylene oxide sterilisation uses a preconditioning phase at 50 °C and 60% RH for 12 h, a gas dwell at 400–800 mg/L for 4–6 h, and forced aeration at 50 °C for 8–24 h; residual ethylene oxide is verified below 4 mg per device for single-use components. Terminal products include inhaler actuator bodies, dose counter housings, vial adaptor shells, and external device enclosures.

    Diagnostic cartridge housings and sample transfer components represent a high-cavitation injection moulding zone where the grade’s nominal MFR of 25 g/10 min under ISO 1133-1:2022 is exploited to fill wall sections of 0.8–1.5 mm, but the same flow orientation requires clamp force control and cavity-pressure monitoring to prevent flash at sealing faces. Compliance is assessed to FDA 21 CFR 177.1520 for direct specimen contact, USP <661.1> for plastic packaging systems, and, for devices with patient sample contact, ISO 10993-1:2018 biological evaluation; manufacturing quality records are normally maintained under ISO 13485:2016. Formulation addition ratio in diagnostic housings is typically 99.0–100 wt% virgin HE2581-PH with 0–1.0 wt% carbon black-free masterbatch; regrind is limited to 10–20 wt% from identical lot production and only after monitoring fluorescence background and extractables according to USP <661.1>. Processing uses multi-cavity cold-runner or hot-runner tools with 16–64 cavities, melt temperature 190–220 °C, mould temperature 15–35 °C, injection speed 100–200 mm/s, holding pressure 30–50 MPa, and total cycle time 10–20 s; dimensional verification after 48 h conditioning at 23 °C and 50% RH is performed by coordinate measuring machine, with capability index Cpk ≥1.33 on critical sealing bosses. Terminal products include lateral flow cartridge bodies, sample well covers, reagent reservoir caps, and diagnostic instrument consumables.

    Compliance and processing boundary matrix for HE2581-PH downstream applications
    Application zonePrimary compliance anchorSecondary test standardsBase resin addition ratioMelt temperature window
    Pharmaceutical closuresFDA 21 CFR 177.1520; Ph. Eur. 3.1.3ISO 8317:2015; USP <661.1>; 16 CFR 1700.2098.0–99.5 wt%200–230 °C
    EO-sterilised device componentsISO 10993-1:2018; ISO 10993-7:2008ISO 10993-5:200999.0–100 wt%190–215 °C
    Diagnostic cartridge housingsFDA 21 CFR 177.1520; USP <661.1>ISO 10993-1:2018; ISO 13485:201699.0–100 wt%190–220 °C
    Solid-dose cold-chain packagingUSP <671>; ASTM D5276-19FDA 21 CFR 177.1520; Ph. Eur. 3.1.398.0–99.5 wt%200–230 °C
    Laboratory reagent consumablesFDA 21 CFR 177.1520; EU 10/2011EN 1186-1; REACH 1907/200699.0–100 wt%190–220 °C
    Nutraceutical/personal-care closuresASTM D1693-15b; FDA 21 CFR 177.1520ISO 527-2; ISO 179-1/1eU; EU 10/201198.0–99.5 wt%190–220 °C

    When Solid-Dose Packaging Must Withstand Cold-Chain Drop Tests Without Fracture

    Cold-chain distribution of solid-dose pharmaceutical packaging introduces a material selection conflict: the same high-density polyethylene that provides moisture-vapour barrier and stiffness at 23 °C can lose ductile response when impact occurs at −20 °C. Container performance is evaluated under USP <671> for moisture vapour permeability where applicable and ASTM D5276-19 for drop testing of loaded containers; material compliance remains FDA 21 CFR 177.1520 and Ph. Eur. monograph 3.1.3. Formulation addition ratio for this zone falls between 98.0–99.5 wt% HE2581-PH and 0.5–2.0 wt% masterbatch, with 0.05–0.20 wt% processing aid; impact modifiers are excluded because they lower flexural modulus and increase moisture vapour transmission per ASTM F1249. Injection moulding with melt temperature 200–230 °C and mould temperature 10–25 °C produces wall sections of 0.7–1.2 mm; injection speed is increased to 120–180 mm/s to suppress hesitation lines at the base radii, and gating is specified as edge fan gates to reduce jetting-related weak points. Post-moulding dimensional stabilisation for 24–48 h at 23 °C and 50% RH precedes cold-chain testing at −20 °C for 24 h, followed by ASTM D5276-19 drop testing at 1.2 m flat drop and 0.8 m edge drop; published data for this specific HE2581-PH configuration is limited, so lot-specific validation is required for wall thickness below 0.7 mm. Terminal product types are solid-dose tubs, metering cups, desiccant canisters, and clinical trial blister overpackaging components.

    Within laboratory reagent packaging and sample-handling consumables, HE2581-PH is processed as a 99.0–100 wt% virgin resin with 0–1.0 wt% masterbatch because any impurity release into trace-analysis aqueous reagents is controlled by FDA 21 CFR 177.1520, EU Regulation (EU) No 10/2011, and REACH Regulation (EC) No 1907/2006; specific migration testing for aqueous simulants is performed per EN 1186-1. Multi-cavity injection moulding with 8–64 cavities uses melt temperature 190–220 °C, mould temperature 15–35 °C, injection speed 80–120 mm/s, and cooling time 8–20 s; cavity-to-cavity mass variation is maintained below 0.5% through hot-runner balancing and screw recovery settings. Terminal products include reagent bottle caps, sample transport containers, microplate racks, and instrument waste containers.

    Nutraceutical and Personal-Care Dispensing Closure Stress-Crack Resistance

    Dispensing closures for nutraceutical oils and personal-care emulsions place HE2581-PH in contact with formulations that may contain terpenes, fatty acids, or ethoxylated surfactants, making environmental stress-crack resistance a primary selection criterion. Performance is assessed using ASTM D1693-15b Condition B in 10% Igepal CO-630, with additional mechanical integrity verified by ISO 527-2 tensile testing and ISO 179-1/1eU Charpy impact; food-contact compliance for nutraceutical closures follows EU Regulation (EU) No 10/2011 and FDA 21 CFR 177.1520. The blend on production equipment is controlled at 98.0–99.5 wt% HE2581-PH, 0.5–2.0 wt% masterbatch, and 0.05–0.15 wt% processing aid; slip agent content is limited to 0.1 wt% because higher slip reduces dynamic coefficient of friction under ISO 8295 and can cause cap back-off in distribution vibration testing per ASTM D999-08. Melt temperature 190–220 °C and mould temperature 15–30 °C are used in multi-cavity cold-runner tools; hold pressure is maintained at 25–45 MPa until gate freeze is confirmed by seal area weight stability. Overpacking at the hinge or living hinge is avoided because frozen-in stress can initiate environmental stress cracking within 24 h of filling, as observed in ASTM D1693-15b test plaques. Terminal products include nutraceutical bottle caps, personal-care flip-top closures, airless pump collars, and lotion pump heads.

    Free Quote

    Competitive Borealis HDPE HE2581-PH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618136850665

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Borealis HDPE HE2581-PH is a blow-moulding high-density polyethylene supplied for rigid pharmaceutical, diagnostic, and personal-care packaging. The grade designation HE2581 identifies the polymer class and melt-flow segment; the -PH suffix denotes a pharmaceutical-grade formulation in which intentionally added slip and antiblock additives are minimised to reduce low-molecular-weight extractable compounds. Melt flow rate is 2.1 g/10 min at 190 °C with a 2.16 kg load when measured by ISO 1133-1:2022. Density is 958 kg/m³ by ISO 1183-1:2019. The resin therefore occupies a medium-viscosity blow-moulding segment with a density high enough to impart stiffness and moisture-vapour resistance but not so high that low-temperature impact is sacrificed. In pharmaceutical packaging operations the material is processed by extrusion blow moulding into narrow-mouth and wide-mouth bottles used for liquid oral dosage forms, dry oral dosage closures, diagnostic reagents, and healthcare containers. Comparative positioning against general-purpose HDPE blow-moulding grades rests on a narrower specification for extractables, improved environmental stress-crack resistance, and stable parison melt strength during die-swell-sensitive operations.

    What separates pharmaceutical blow-moulding HDPE from conventional unimodal grades?

    Conventional unimodal HDPE blow-moulding resins with equivalent melt flow rate and density are often formulated with slip agents, antiblock agents, or processing aids that can increase total organic carbon in aqueous extraction tests. HE2581-PH is supplied under a formulation policy that avoids these additives in the base blend; the result is a lower pellet-surface additive layer and reduced migration of lubricant species into filled containers. The absence of slip agent has a processing consequence: the coefficient of friction between finished bottles is higher than that of general-purpose grades, and unscrambling or conveying equipment may require contact-surface adjustments. In addition, the resin is not colour- or antioxidant-loaded in a way that masks variability in the base polymer under sensory testing.

    The polymer architecture of HE2581-PH is controlled for a balance of stress-crack resistance and stiffness. Environmental stress-crack resistance is measured under ASTM D1693 in a 100 % Igepal solution at 50 °C; reported typical values exceed 300 h, which is above many unimodal HDPE blow-moulding grades of comparable 958 kg/m³ density. Notched Charpy impact strength is reported at 8.0 kJ/m² at 23 °C according to ISO 179-1:2023. Tensile yield stress is 28 MPa under ISO 527-2:2012, and flexural modulus is 1250 MPa under ISO 178:2019. These properties are interrelated: an increase in density would raise flexural modulus and moisture-vapour barrier but reduce stress-crack resistance and low-temperature impact; a decrease in melt flow rate would improve ESCR but reduce extruder output and increase shear heating. The selected balance is relevant to pharmaceutical containers that require drop resistance after filling and resistance to crazing when exposed to aggressive soaps, alcohols, or diagnostic reagents.

    In comparison with polypropylene random copolymers used for pharmaceutical bottles, HE2581-PH has higher moisture-vapour barrier and higher environmental stress-crack resistance but lower optical clarity and lower resistance to autoclave sterilisation. In comparison with polyethylene terephthalate, the HDPE grade has lower modulus and lower oxygen barrier but provides better ESCR and a more ductile failure mode under squeeze-to-dispense use. Within Borealis high-density polyethylene blow-moulding grades, the -PH version is differentiated by extractables control rather than by an increase in melt-flow or density; a non-PH grade with the same 2.1 g/10 min MFR may be unsuitable for pharmacopoeial packaging because its additive package is not qualified for highly purified, low-migration containers.

    A representative property profile compiled from publicly available manufacturer technical literature is presented below. Values are typical and do not constitute a release specification; exact limits are controlled by the current datasheet and quality agreement.

    PropertyTypical valueTest method
    Melt flow rate (190 °C/2.16 kg)2.1 g/10 minISO 1133-1:2022
    Density958 kg/m³ISO 1183-1:2019
    Tensile stress at yield28 MPaISO 527-2:2012
    Tensile elongation at break>600 %ISO 527-2:2012
    Flexural modulus1250 MPaISO 178:2019
    Notched Charpy impact strength at 23 °C8.0 kJ/m²ISO 179-1:2023
    Vicat softening temperature A50 (10 N)127 °CISO 306:2022
    Environmental stress-crack resistance>300 hASTM D1693
    Hardness62 Shore DISO 868:2003

    From the table, density is a critical control parameter. A shift of 0.002 g/cm³ upward moves the grade closer to the high-density stiffening knee where stress-crack resistance declines, while a similar downward shift reduces top-load strength in lightweight bottles. The melt flow rate of 2.1 g/10 min gives moderate screw back-pressure during blow moulding; the shear viscosity under ISO 11443 capillary testing is not routinely supplied but is implied by the MFR and the known high-density polyethylene molecular weight distribution. The notched Charpy value of 8.0 kJ/m² at 23 °C should not be extrapolated to filled-container drop performance because wall thickness, pinch-off weld integrity, and stress concentration at the neck–shoulder transition dominate failure. Bottle drop testing is therefore required under ASTM D2463 or equivalent filled-container protocols. Similarly, top-load testing of finished bottles should follow ASTM D2659 or an agreed crush-test procedure, because top-load strength depends on sidewall geometry, distribution, and mould cooling history.

    The Vicat softening temperature of 127 °C under ISO 306/A50 is a short-term thermal index; it does not imply continuous operational use at that temperature. For HDPE containers under load, continuous use is typically restricted to below 80 °C, and even short excursions above 100 °C can produce dimensional distortion without reaching the Vicat point. This distinction is relevant for filling lines that may use hot-water rinses or tunnel drying.

    When parison programming shifts from general-purpose containers to narrow-mouth pharmaceutical bottles

    Extrusion blow moulding of HE2581-PH is performed at melt temperatures between 180 °C and 220 °C. The lower bound is set by melt viscosity and screw torque; the upper bound is set by thermal degradation and parison sag. Production lines typically use single-screw extruders with barrier screws and L/D 24:1 to 30:1. Head pressure in the accumulator or continuous die depends on die gap, output, and melt temperature; a representative range is 100 bar to 350 bar. Pressures above 350 bar have been associated with gel formation or insufficient melting, while pressures below 100 bar may indicate worn screw or barrel clearances. Published data for a specific line configuration are limited, and these values are general blow-moulding operating windows rather than product-specific guarantees.

    Because die-swell characteristics are controlled by the molecular weight distribution, grade change from a general-purpose HDPE to HE2581-PH requires re-setting the die gap and reprogramming the parison wall profile. The change can shift sidewall thickness in the waist region and move the pinch-off line. A die-gap increase of 5 % to 10 % is the typical initial correction on shuttle machines, but the final setting is bottle-geometry dependent. Wall-thickness distributions should be measured by ultrasonic or magnified sectioning before committing to process validation. The pinch-off weld is a critical failure site; insufficient clamp force or a badly programmed tail flash can produce weld-line notches that act as impact initiation points. Blow moulds are typically run at 10 °C to 30 °C to freeze the parison surface rapidly. A mould temperature below 10 °C can cause surface defects and condensation; above 35 °C, cycle time increases and wall crystallinity may rise, lowering impact toughness.

    Pre-drying is not normally required. The polymer is hydrophobic, but surface moisture picked up in high-humidity storage can generate splay and voids. When relative humidity exceeds 60 %, a desiccant hopper set at 80 °C for 2 h is sufficient. Regrind use in pharmaceutical packaging is qualification-dependent. Clean, uncontaminated in-house regrind up to 20 wt% is often acceptable in non-sterile packaging lines, but many pharmaceutical validations limit regrind to lower levels or require documented heat histories. Degraded regrind from multiple heat cycles reduces ESCR and increases gel count; it should not be used in high-gloss or high-impact applications. Colour masterbatch loading for opaque white or pastel pharmaceutical bottles is typically 2 wt% to 4 wt%; higher inorganic pigment loadings can reduce ESCR by creating stress concentrations at pigment agglomerates, and the carrier resin must be compatible with the -PH extractables profile.

    Compliance of the raw material with pharmaceutical and food-contact regulations is listed below. The resin supplier supports these standards at the pellet level, but finished container compliance remains the responsibility of the converter and marketer.

    Regulatory domainStandard or referenceScope and limitation
    European Union food contactRegulation (EC) No 1935/2004; Regulation (EU) No 10/2011 and amendmentsOverall migration and specific migration limits must be determined on the final article.
    United States food contact21 CFR 177.1520Olefin polymers for food contact, subject to conditions of use and final article extraction testing.
    Pharmacopoeial packagingPh. Eur. 3.1.3 Polyolefins; USP <661.1>Testing applies to the plastic packaging system, not the raw resin alone.
    Biocompatibility supportISO 10993-5; ISO 10993-10Finished device evaluation is required; pellet-level data are supportive only.
    Chemical regulationREACH Regulation (EC) No 1907/2006; RoHS Directive 2011/65/EUSVHC declarations and restricted-substance compliance are supplier-documented.

    The pharmacopoeial standards do not provide blanket approval of the resin. They define extractable-metal limits, total organic carbon, and identity tests on the packaged article. The -PH formulation is intended to support low extractable profiles, but the converter must verify that the combination of blow-moulding temperature, regrind, and colourant does not change the profile. Raw-resin lot data cannot replace finished-container stability studies under ICH Q1A where the package holds a pharmaceutical product. Similarly, ISO 10993 testing is a finished-device requirement; the resin alone is not a medical device, and the conversion process, sterilisation, and leachables from tooling may introduce new risks.

    Residual metal control, organoleptic neutrality, and steam sterilisation boundaries

    The -PH designation imposes restrictions on residual transition-metal and ash content because these species can migrate into liquid formulations under acidic or chelating conditions. Organoleptic neutrality is evaluated by odour and taste transfer tests on blow-moulded containers; the base resin is formulated to avoid volatile species that impart off-taste. This does not remove all off-taste risk: oxygenated degradation products generated by excessive melt temperature or by repeated regrind can still contaminate packaged contents. Melt temperature should therefore remain below 220 °C to limit thermo-oxidative product formation. Odour and taste transfer can be measured by ASTM E1870 or equivalent sensory methods; the -PH formulation is designed for low taint, but final container sensory performance depends on process history and masterbatch choice.

    The resin is not suitable for steam sterilisation at 121 °C. The Vicat softening temperature of 127 °C under ISO 306/A50 is a short-term heat-distortion indicator, but the actual continuous-use temperature of HDPE is lower, and autoclave load produces irreversible deformation. Suitable sterilisation routes for this polyolefin are limited to ethylene oxide at 55 °C or lower, electron-beam irradiation, or gamma irradiation under controlled dose. Gamma doses above 25 kGy can increase carbonyl formation and reduce notched impact strength; dose mapping is required because the radiation response of finished bottles depends on wall thickness and antioxidant package. Dry heat above 80 °C is not recommended. The grade should not be blended with unqualified amine-based antioxidant masterbatches or processing aids that raise extractable nitrogen species, because such additions can invalidate organoleptic and pharmacopoeial qualification.

    Production-scale qualification of HE2581-PH for pharmaceutical oral-dosage containers includes top-load, drop-impact, and extraction studies. Top-load values are bottle-geometry dependent but generally rise with density and sidewall thickness; the 958 kg/m³ density provides a stiffness baseline for 100 mL to 250 mL bottles. Drop-impact acceptance testing is usually performed at 4 °C or room temperature after conditioning according to ASTM D2463; the resin-level notched Charpy value of 8.0 kJ/m² at 23 °C does not replace this test. Sealing integrity of induction-sealed and child-resistant closures must be tested separately because the absence of slip agents changes cap-on-bottle torque and liner adhesion. For containers exposed to dilute soaps, alcohol-based hand rubs, or diagnostic reagents, stress-crack testing on filled bottles is preferred over resin-level ESCR data alone; the final bottle should be tested under the specific contact medium and temperature conditions of use.

    Top